Advances in immunotherapy for MMR proficient colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in immunotherapy for MMR proficient colorectal cancer

Published:2022-12 Issue: Volume:111 Page:102480
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Lote Hazel,Starling Naureen,Pihlak Rille,Gerlinger Marco

Funder

NIHR Cambridge Biomedical Research Centre

Cancer Research UK

Institute of Cancer Research

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference111 articles.

1. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014

2. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study;Saltz;J Clin Oncol,2008

3. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen;Van Cutsem;Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2012

4. Randomized trial of TAS-102 for refractory metastatic colorectal cancer;Mayer;N Engl J Med,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer;Future Oncology;2024-07-23

2. Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD‐mediated pyroptosis in colorectal cancer;Clinical and Translational Medicine;2024-05-28

3. Mechanisms of metastatic colorectal cancer;Nature Reviews Gastroenterology & Hepatology;2024-05-28

4. Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment;British Journal of Cancer;2024-05-15

5. Financial toxicity of informal caregivers of colorectal cancer patients: A cross-sectional study;European Journal of Oncology Nursing;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3